Abstract
Objective The main purpose of this article is to explore the current practice for follow-up of gynecological cancer, pointing out the different procedures, to determine the most clinically and cost-effective surveillance strategies after the primary treatment. Materials and Methods We analyzed the follow up strategies for ovarian, endometrial, and cervical cancer.
All of the topics discussed below arose from the ESGO State of Art ConferenceFollow-up in gynaecological malignancies in Turin, (September 11-13, 2014; http://torino2014.esgo.org/). Results Physical but these practices should be integrated with biomarkers or imaging strategies.
Currently, most recommendations about follow-up are based on retrospective studies and expert opinion, and there is some disagreement on surveillance strategies due to lack of evidence-based knowledge. Conclusions All surveillance procedures should be evidence-based with a clearly defined purpose: there is a need for prospective studies to compare the effectiveness of different follow-up regimens measuring overall survival, detection of recurrence, quality of life (QoL), and costs as outcomes.